Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Jones

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancerF A Holmes, J A O'Shaughnessy, S Vukelja, et al.
Cancer|March 15, 1983
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group StudyS E Jones, P N Grozea, E N Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trialC K Osborne, J Pippen, S E Jones, et al.
Cancer|October 1, 1976
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphomaE M McKelvey, J A Gottlieb, H E Wilson, et al.
Cancer|February 1, 1979
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group studyS E Jones, P N Grozea, E N Metz, et al.
Clinical Transplantation|February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancerR P Gale, R E Park, R Dubois, et al.
European Journal of Neurology|March 30, 2020
Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metricsG Macaron, L E Baldassari, K Nakamura, et al.
Epilepsy Research|March 7, 2012
Voxel-based morphometric MRI post-processing in MRI-negative focal cortical dysplasia followed by simultaneously recorded MEG and stereo-EEGZ I Wang, S E Jones, A J Ristic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2002
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancerF A Holmes, J A O'Shaughnessy, S Vukelja, et al.
Cancer|March 15, 1983
Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy. A Southwest Oncology Group StudyS E Jones, P N Grozea, E N Metz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trialC K Osborne, J Pippen, S E Jones, et al.
Cancer|October 1, 1976
Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphomaE M McKelvey, J A Gottlieb, H E Wilson, et al.
Cancer|February 1, 1979
Superiority of adriamycin-containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group studyS E Jones, P N Grozea, E N Metz, et al.
Clinical Transplantation|February 29, 2000
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in women with breast cancerR P Gale, R E Park, R Dubois, et al.
European Journal of Neurology|March 30, 2020
Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment and magnetic resonance imaging metricsG Macaron, L E Baldassari, K Nakamura, et al.
Epilepsy Research|March 7, 2012
Voxel-based morphometric MRI post-processing in MRI-negative focal cortical dysplasia followed by simultaneously recorded MEG and stereo-EEGZ I Wang, S E Jones, A J Ristic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1996
Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancerS E Jones, M W Schottstaedt, L A Duncan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Pageof 26